Pharma-Bio Serv (PBSV) Gross Margin (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Gross Margin of 33.37% for Q2 2026, down 50.0% year-over-year from 66.75% in Q2 2025, and up 6.02% on a QoQ basis from 31.48% in Q1 2026.
Pharma-Bio Serv (PBSV) Gross Margin (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Gross Margin history runs 16 years deep, the most recent figure standing at 33.37% for Q2 2026.
- Gross Margin for Q2 2026 came in at 33.37%, down 50.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 32.35% (up 176.0% YoY), and the FY2025 annual result was 32.33%, up 587.0% from the prior year.
- Gross Margin came in at 33.37% for Q2 2026 at Pharma-Bio Serv, up from 31.48% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 34.84% in Q4 2025 to a low of 22.5% in Q1 2024.
- A 5-year average of 28.83% and a median of 29.26% in 2023 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin slumped 759 bps in 2024 and surged 858 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 23.9% in 2022, then increased by 8 bps to 25.84% in 2023, then gained by 21 bps to 31.14% in 2024, then increased by 12 bps to 34.84% in 2025, then dropped by 4 bps to 33.37% in 2026.
- The last three Gross Margin figures came in at 33.37% (Q2 2026), 31.48% (Q1 2026), and 34.84% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 74.98% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 13.34% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 72.27% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 84.60% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 70.39% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 86.65% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 85.40% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 98.65% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 45.30% |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 33.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 33.37% |
| Jan 31, 2026 | 31.48% |
| Oct 31, 2025 | 34.84% |
| Jul 31, 2025 | 29.25% |
| Apr 30, 2025 | 33.87% |
| Jan 31, 2025 | 31.08% |
| Oct 31, 2024 | 31.14% |
| Jul 31, 2024 | 26.28% |
| Apr 30, 2024 | 26.01% |
| Jan 31, 2024 | 22.50% |
| Oct 31, 2023 | 25.84% |
| Jul 31, 2023 | 33.86% |
| Apr 30, 2023 | 29.51% |
| Jan 31, 2023 | 29.26% |
| Oct 31, 2022 | 23.90% |
| Jul 31, 2022 | 27.49% |
| Apr 30, 2022 | 24.48% |
| Jan 31, 2022 | 24.80% |
| Oct 31, 2021 | 26.78% |
| Jul 31, 2021 | 25.16% |